BridgeBio Pharma, Inc. (BBIO): SCHEDULE 13G filed May 29, 2026

Form type

SCHEDULE 13G

Filing date

May 29, 2026

Accession number

0000908834-26-000252

Filer

BridgeBio Pharma, Inc. (CIK 1743881)